Literature DB >> 22403331

Dengue hemorrhagic fever in Trinidad and Tobago: a case for a conservative approach to platelet transfusion.

Anu Sharma1, Kenneth Charles, Dave Chadee, Surujpaul Teelucksingh.   

Abstract

Dengue fever is endemic to Trinidad and Tobago. A retrospective analysis of all adult admissions at a tertiary hospital in Trinidad treated for dengue during January 1-December 31, 2008 was performed. A total of 186 patients were treated during this period: 98.9% (184) of the patients were thrombocytopenic; 45.2% were severely thrombocytopenic; 13 patients showed development of minor hemorrhage and only one case of major hemorrhage; platelet transfusion was given for 7% (13) of the cases; and 6 cases for which platelet transfusion was given did not show evidence of plasma leakage (12 of these cases did not show evidence of hemorrhage). There was a strong association between the lowest platelet value and hemoconcentration (χ(2) = 13.16, P < 0.025). No association was found between giving a platelet transfusion and hemoconcentration or hemorrhage. Thrombocytopenia seen in dengue resolves spontaneously and independent of any transfusion used.

Entities:  

Mesh:

Year:  2012        PMID: 22403331      PMCID: PMC3284376          DOI: 10.4269/ajtmh.2012.10-0209

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Determinants and predictors of dengue infection in Mexico.

Authors:  J S Koopman; D R Prevots; M A Vaca Marin; H Gomez Dantes; M L Zarate Aquino; I M Longini; J Sepulveda Amor
Journal:  Am J Epidemiol       Date:  1991-06-01       Impact factor: 4.897

Review 2.  Dengue: current trends and challenges--an Indian perspective.

Authors:  G Ahluwalia; S K Sharma
Journal:  J Assoc Physicians India       Date:  2004-07

3.  Climate, mosquito indices and the epidemiology of dengue fever in Trinidad (2002-2004).

Authors:  D D Chadee; B Shivnauth; S C Rawlins; A A Chen
Journal:  Ann Trop Med Parasitol       Date:  2007-01

4.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Authors:  P C Hébert; G Wells; M A Blajchman; J Marshall; C Martin; G Pagliarello; M Tweeddale; I Schweitzer; E Yetisir
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

5.  Severe dengue virus infection in travelers: risk factors and laboratory indicators.

Authors:  Ole Wichmann; Joaquim Gascon; Mirjam Schunk; Sabino Puente; Heli Siikamaki; Ida Gjørup; Rogelio Lopez-Velez; Joannes Clerinx; Gabriele Peyerl-Hoffmann; Anders Sundøy; Blaise Genton; Peter Kern; Guido Calleri; Miguel de Górgolas; Nikolai Mühlberger; Tomas Jelinek
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

6.  Dengue haemorrhagic fever/dengue shock syndrome. An unwelcome arrival in Trinidad.

Authors:  S Teelucksingh; A S Mangray; S Barrow; N Jankey; P Prabhakar; M Lewis
Journal:  West Indian Med J       Date:  1997-06       Impact factor: 0.171

7.  Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.

Authors:  David C Lye; Vernon J Lee; Yan Sun; Yee Sin Leo
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

Review 8.  Is dengue a threat to the blood supply?

Authors:  D Teo; L C Ng; S Lam
Journal:  Transfus Med       Date:  2009-04       Impact factor: 2.019

9.  Evaluation of commercially available anti-dengue virus immunoglobulin M tests.

Authors:  Elizabeth A Hunsperger; Sutee Yoksan; Philippe Buchy; Vinh Chau Nguyen; Shamala D Sekaran; Delia A Enria; Jose L Pelegrino; Susana Vázquez; Harvey Artsob; Michael Drebot; Duane J Gubler; Scott B Halstead; María G Guzmán; Harold S Margolis; Carl-Michael Nathanson; Nidia R Rizzo Lic; Kovi E Bessoff; Srisakul Kliks; Rosanna W Peeling
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

10.  Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E.

Authors:  Panisadee Avirutnan; Lijuan Zhang; Nuntaya Punyadee; Ananya Manuyakorn; Chunya Puttikhunt; Watchara Kasinrerk; Prida Malasit; John P Atkinson; Michael S Diamond
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

View more
  3 in total

1.  Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients.

Authors:  Tau-Hong Lee; Joshua G X Wong; Yee-Sin Leo; Tun-Linn Thein; Ee-Ling Ng; Linda K Lee; David C Lye
Journal:  PLoS Negl Trop Dis       Date:  2016-03-25

Review 2.  Epidemiological Characteristics of Dengue Disease in Latin America and in the Caribbean: A Systematic Review of the Literature.

Authors:  Jaime Rafael Torres; Tomás Agustín Orduna; Maricela Piña-Pozas; Daniela Vázquez-Vega; Elsa Sarti
Journal:  J Trop Med       Date:  2017-03-14

3.  Prophylactic platelets in dengue: survey responses highlight lack of an evidence base.

Authors:  James Whitehorn; Rosmari Rodriguez Roche; Maria G Guzman; Eric Martinez; Wilmar Villamil Gomez; Leonard Nainggolan; Ida Safitri Laksono; Ajay Mishra; Lucy Lum; Abul Faiz; Amadou Sall; Joshua Dawurung; Alvaro Borges; Yee-Sin Leo; Lucille Blumberg; Daniel G Bausch; Axel Kroeger; Olaf Horstick; Guy Thwaites; Heiman Wertheim; Mattias Larsson; Tran Tinh Hien; Rosanna Peeling; Bridget Wills; Cameron Simmons; Jeremy Farrar
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.